Company Neurokine Pharmaceuticals Inc Other OTC
Equities
CAC611561100
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
05-03 | BetterLife Pharma Inc. announced that it expects to receive CAD 0.5 million in funding | CI |
05-01 | BetterLife Pharma Advances IND-enabling Studies For BETR-001 | MT |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 16/09/07 |
Moira Ong
DFI | Director of Finance/CFO | 49 | 25/12/10 |
Chief Operating Officer | 67 | - | |
Wolfgang Renz
BRD | Director/Board Member | 54 | 04/02/15 |
David Melles
IRC | Investor Relations Contact | - | 28/09/21 |
Anthony Calandra
LAW | General Counsel | - | - |
Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 16/09/07 |
Robert Metcalfe
BRD | Director/Board Member | 84 | 20/01/20 |
Wolfgang Renz
BRD | Director/Board Member | 54 | 04/02/15 |
Ralph Pullen
BRD | Director/Board Member | 79 | 04/05/20 |
Steven Sangha
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 113,825,305 | 88,051,525 ( 77.36 %) | 0 | 77.36 % |
Company contact information
BetterLife Pharma, Inc.
1275 West 6th Avenue Suite 300
V6H 1A6, Vancouver
+604 221 0595
http://www.abetterlifepharma.comSector
1st Jan change | Capi. | |
---|---|---|
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- BETRF Stock
- Stock
- Company Neurokine Pharmaceuticals Inc